EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin’s lymphoma

Tatsuo Oyake, Takahiro Maeta, Takenori Takahata, Yoshiko Tamai, Yoshihiro Kameoka, Naoto Takahashi, Yasuro Miyairi, Kazunori Murai, Kenji Shimosegawa, Kozue Yoshida, Kyoko Inokura, Noriko Fukuhara und 12 weitere

Journal of Clinical and Experimental Hematopathology · 2024

DOI: 10.3960/jslrt.24021 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2024. Verfasst von Tatsuo Oyake und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan. Hauptthemen laut MEDLINE: Hodgkin Disease, Immune Checkpoint Inhibitors. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hodgkin DiseaseImmune Checkpoint InhibitorsHumansMaleRetrospective StudiesFemaleMiddle AgedAdultAgedAntibodies, Monoclonal, HumanizedNivolumabYoung AdultRecurrenceAdolescent

Stichwörter der Autor:innen

classical Hodgkin’s lymphomaimmune checkpoint inhibitorsreal-world settingrelapsing and refractory cHL

Substanzen

Immune Checkpoint InhibitorsAntibodies, Monoclonal, HumanizedNivolumabpembrolizumab

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan.
  • Department of Gastroenterology, Hematology and Clinical Immunology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Department of Transfusion and Cell Therapy Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.
  • Division of Hematology, Iwate Prefectural Central Hospital, Morioka, Japan.
  • Division of Hematology, Iwate Prefectural Chubu Hospital, Kitakami, Japan.

Zitieren

APA

Oyake, T., Maeta, T., Takahata, T., Tamai, Y., Kameoka, Y., Takahashi, N., Miyairi, Y., Murai, K., Shimosegawa, K., Yoshida, K., Inokura, K., Fukuhara, N., Harigae, H., Sato, R., Ishizawa, K., Tajima, K., Saitou, S., Fukatsu, M., Ikezoe, T., …, & Ito, S. (2024). Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin’s lymphoma. Journal of Clinical and Experimental Hematopathology. https://doi.org/10.3960/jslrt.24021

Vancouver

Oyake T, Maeta T, Takahata T, Tamai Y, Kameoka Y, Takahashi N, et al. Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin’s lymphoma. Journal of Clinical and Experimental Hematopathology. 2024. doi:10.3960/jslrt.24021

BibTeX
@article{Oyake2024,
  author = {Oyake, Tatsuo and Maeta, Takahiro and Takahata, Takenori and Tamai, Yoshiko and Kameoka, Yoshihiro and Takahashi, Naoto and Miyairi, Yasuro and Murai, Kazunori and Shimosegawa, Kenji and Yoshida, Kozue and Inokura, Kyoko and Fukuhara, Noriko and Harigae, Hideo and Sato, Ryo and Ishizawa, Kenichi and Tajima, Katsushi and Saitou, Souichi and Fukatsu, Masahiko and Ikezoe, Takayuki and Tsunoda, Saburo and Mita, Masayuki and Mori, Jinichi and Kowata, Shugo and Ito, Shigeki},
  title = {Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin’s lymphoma},
  journal = {Journal of Clinical and Experimental Hematopathology},
  year = {2024},
  doi = {10.3960/jslrt.24021}
}
Kostenlos starten →